pubmed.ncbi.nlm.nih.gov

An innovative approach for migraine prevention in young age: a preliminary study - PubMed

An innovative approach for migraine prevention in young age: a preliminary study

Susanna Usai et al. Neurol Sci. 2010 Jun.

Abstract

Headache is one of the commonest conditions to affect children and adolescents in industrialized countries. Effective pharmacological treatments without side effects are still lacking. Ginkgolide B, an herbal constituent extract from ginkgo biloba tree leaves, is a natural antiplatelet activating factor (PAF). PAF is a potent proinflammatory and nociceptive agent released during the inflammation process. Therefore, Ginkgolide B can be considered a promising non-pharmacological tool for treatment of migraine with and without aura. We propose to determine the efficacy of Ginkgolide B as preventive treatment in a group of young patients suffering from migraine without aura. A small sample of 24 young patients suffering from migraine without aura entered the open-label prospective trial. Migraine without aura was diagnosed according to International Headache Society criteria. The treatment was well tolerated and the compliance was good. These preliminary data show that Ginkgolide B seems to be effective as preventive treatment in reducing migraine attack frequency and in attenuating the use of symptomatic medication in our small series of children with primary headache.

PubMed Disclaimer

Cited by

Herbal therapy in migraine.
D'Andrea G, Cevoli S, Cologno D. D'Andrea G, et al. Neurol Sci. 2014 May;35 Suppl 1:135-40. doi: 10.1007/s10072-014-1757-x. Neurol Sci. 2014. PMID: 24867850 Review.
Phytomedicines in the Treatment of Migraine.
Rajapakse T, Davenport WJ. Rajapakse T, et al. CNS Drugs. 2019 May;33(5):399-415. doi: 10.1007/s40263-018-0597-2. CNS Drugs. 2019. PMID: 30627973 Review.
Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up.
Usai S, Grazzi L, Bussone G. Usai S, et al. Neurol Sci. 2011 May;32 Suppl 1(Suppl 1):S197-9. doi: 10.1007/s10072-011-0522-7. Neurol Sci. 2011. PMID: 21533745 Free PMC article. Clinical Trial.
Using Sleep Time Data from Wearable Sensors for Early Detection of Migraine Attacks.
Siirtola P, Koskimäki H, Mönttinen H, Röning J. Siirtola P, et al. Sensors (Basel). 2018 Apr 28;18(5):1374. doi: 10.3390/s18051374. Sensors (Basel). 2018. PMID: 29710791 Free PMC article.
Complementary and Integrative Medicines as Prophylactic Agents for Pediatric Migraine: A Narrative Literature Review.
Yamanaka G, Kanou K, Takamatsu T, Takeshita M, Morichi S, Suzuki S, Ishida Y, Watanabe Y, Go S, Oana S, Kawashima H. Yamanaka G, et al. J Clin Med. 2021 Jan 3;10(1):138. doi: 10.3390/jcm10010138. J Clin Med. 2021. PMID: 33401551 Free PMC article. Review.

References

1. Bille B. Migraine in childhood and its prognosis. Cephalalgia. 1981;1:71–75. doi: 10.1111/j.1468-2982.1981.tb00012.x. - DOI - PubMed
1. Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics. 2003;112:e1–e5. doi: 10.1542/peds.112.1.e1. - DOI - PubMed
1. Abu-Arefeh I, Russel G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309:765–769. - PMC - PubMed
1. Grazzi L, Andrasik F, Usai S, Bussone G. Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. Neurol Sci. 2007;28(3):148–150. doi: 10.1007/s10072-007-0808-y. - DOI - PubMed
1. Andrasik F, Grazzi L, Usai S, Bussone G. Pharmacological treatment compared to behavioural treatment for juvenile tension-type headache: results at two-year follow-up. Neurol Sci. 2007;28(Suppl2):S235–S238. doi: 10.1007/s10072-007-0786-0. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

An innovative approach for migraine prevention in young age: a preliminary study - PubMed